Ibrutinib in primary central nervous system diffuse large B-cell lymphoma
The standard regimen for the treatment of newly diagnosed primary CNS lymphoma (PCNSL) remains regimens that contain high-dose methotrexate (MTX). While these regimens can provide control for some patients, there is a dearth of options for the treatment of patients with PCNSL who cannot tolerate MTX...
Guardat en:
| Autors principals: | , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Taylor & Francis Group
2020-03-01
|
| Col·lecció: | CNS Oncology |
| Matèries: | |
| Accés en línia: | https://www.futuremedicine.com/doi/10.2217/cns-2019-0022 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|